tiprankstipranks
Trending News
More News >
Aldeyra’s reproxalap  achieves primary endpoint in Phase 3 dry eye disease trial
PremiumThe FlyAldeyra’s reproxalap achieves primary endpoint in Phase 3 dry eye disease trial
1M ago
Aldeyra Therapeutics Appoints Chip Clark to Board
Premium
Company Announcements
Aldeyra Therapeutics Appoints Chip Clark to Board
2M ago
Aldeyra options imply 12.1% move in share price post-earnings
Premium
The Fly
Aldeyra options imply 12.1% move in share price post-earnings
2M ago
Aldeyra Therapeutics: Buy Rating Affirmed Amid Promising Developments and Robust Financial Health
PremiumRatingsAldeyra Therapeutics: Buy Rating Affirmed Amid Promising Developments and Robust Financial Health
2M ago
Aldeyra Therapeutics Receives FDA Complete Response Letter
Premium
Company Announcements
Aldeyra Therapeutics Receives FDA Complete Response Letter
2M ago
Aldeyra options imply 35.3% move in share price post-earnings
Premium
The Fly
Aldeyra options imply 35.3% move in share price post-earnings
2M ago
Aldeyra options imply 30.8% move in share price post-earnings
PremiumThe FlyAldeyra options imply 30.8% move in share price post-earnings
3M ago
Aldeyra Therapeutics: Buy Rating Affirmed on Promising Reproxalap and Strategic RASP Market Expansion
Premium
Ratings
Aldeyra Therapeutics: Buy Rating Affirmed on Promising Reproxalap and Strategic RASP Market Expansion
3M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100